This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AANMA Supports Prescription-Only Pseudoephedrine Legislation

MCLEAN, Va., Feb. 13, 2013 /PRNewswire-USNewswire/ -- Meth addiction is a worldwide epidemic of unimaginable proportions, with an estimated 15,000 deaths in the United States alone last year. States with prescription-only pseudoephedrine laws show a decrease in meth labs, according to a Government Accountability Office (GAO) report released today.

Allergy & Asthma Network Mothers of Asthmatics (AANMA) supports legislation to return pseudoephedrine (PSE) medications to the prescription-only status they held prior to 1976. PSE, a sinus decongestant, is not included as an appropriate asthma medication in the National Institutes of Health Guidelines for the Diagnosis and Management of Asthma.

"Pseudoephedrine hydrochloride, which is the key ingredient for the manufacturing of methamphetamines, does not serve a significant role in the care of patients who suffer from allergic or non-allergic rhinitis," says Stuart W. Stoloff, MD, FAAAAI, FAAFP, clinical professor of family and community medicine, University of Nevada School of Medicine. "Other medications including saline offer a safer option when treating nasal congestion whether it be associated with the common cold, allergic, or non-allergic rhinitis. Given the enhanced safety profile of these other medications, there is no role for pseudoephedrine hydrochloride to be readily available to patients as a 'behind the counter' medication that does not require a prescription written by a qualified medical practitioner."

In 28 years, AANMA has never heard from asthma and allergy patients who rely on non-prescription oral decongestants for their condition.

The most recent data from law enforcement indicates that diversion of legally produced PSE to methamphetamine production in small, toxic "one-pot" labs continues to rise everywhere except in the two states ( Oregon in 2006, Mississippi in 2010) where a prescription is now required. Thus, it seems almost ludicrous not to take advantage of an easy solution to the meth lab problem that requires only the stroke of a pen for implementation.

Preventing the diversion of PSE to the manufacture of methamphetamine is far more urgent and vital to the public interest than continued availability of any particular remedy for the common cold.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,745.98 -5.41 -0.03%
S&P 500 2,108.63 +0.06 0.00%
NASDAQ 5,128.7850 +17.0520 0.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs